BlossomHill Therapeutics
San Diego, US · Founded 2020 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JJ
JINGRONG JEAN CUIExecutive Officer, Director
YL
YISHAN LIExecutive Officer, Director
JJ
Jingrong Jean CuiExecutive Officer, Director
LP
Li Peter YishanExecutive Officer, Director
GL
GEORGE LEEDirector
CG
CARL GORDONDirector
SA
SUNDEEP AGRAWALDirector
BC
BIHUA CHENDirector
TS
TIMOTHY STUBBSDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$84.2MraisedDec 2025 · 47 investors · PharmaceuticalsRule 506(b)
▶$84.2MraisedDec 2025 · 47 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- GEORGE LEEDirector
- CARL GORDONDirector
- YISHAN LIExecutive Officer, Director
- SUNDEEP AGRAWALDirector
- BIHUA CHENDirector
- TIMOTHY STUBBSDirector
- JINGRONG JEAN CUIExecutive Officer, Director
- Offering amount
- $84.2M
- Amount sold
- $84.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$88.6MraisedJan 2024 · 44 investors · PharmaceuticalsRule 506(b)
▶$88.6MraisedJan 2024 · 44 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sundeep AgrawalDirector
- Jingrong Jean CuiExecutive Officer, Director
- Bihua ChenDirector
- George LeeDirector
- Carl GordonDirector
- Yishan LiExecutive Officer, Director
- Hongbo LuDirector
- Offering amount
- $100M
- Amount sold
- $88.6M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$71MraisedMar 2021 · 27 investors · PharmaceuticalsRule 506(b)
▶$71MraisedMar 2021 · 27 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George LeeDirector
- Li Peter YishanExecutive Officer, Director
- Bihua ChenDirector
- Carl GordonDirector
- Jingrong Jean CuiExecutive Officer, Director
- Offering amount
- $71M
- Amount sold
- $71M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedJan 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedJan 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jingrong Jean CuiExecutive Officer, Director
- Li Peter YishanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.